UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share
UPH.WS
UPH.WS was delisted on the 27th of November, 2023.
20 hedge funds and large institutions have $5.8M invested in UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share in 2021 Q2 according to their latest regulatory filings, with 20 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LA
Linden Advisors
New York
|
+$1.51M |
| 2 |
ICM
Ionic Capital Management
New York
|
+$1.28M |
| 3 |
MAMNY
Marathon Asset Management (New York)
New York
|
+$1.12M |
| 4 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$780K |
| 5 |
DKCM
Davidson Kempner Capital Management
New York
|
+$585K |
Top Sellers
UPH.WS Hedge Fund Activity: Q2 2021 in Review
20 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share (UPH.WS) for Q2 2021, worth a combined $5.8M.
Buyers outnumbered sellers: 20 funds opened new UPH.WS positions and 0 closed out — a net gain of 20 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Linden Advisors, opening a new position worth an estimated $1.51M.
- 20 institutional investors held UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share (UPH.WS) as of Q2 2021, up from 0 in Q1 2021.
- Funds reported $5.8M of UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share stock for Q2 2021.
- 20 funds opened new UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share positions in Q2 2021 and 0 closed out, a net change of +20 holders.
- The largest UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share buyer in Q2 2021 was Linden Advisors, an estimated $1.51M added.
Based on aggregated 13F filings for Q2 2021.